DNA adduct formation in the human nasal mucosa as a biomarker of exposure to environmental mutagens and carcinogens

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 3, 1996, Pages 471-473

  Flato, Sylwia ^a   Hemminki, Kari ^b   Thunberg, Eva ^a   Georgellis, Antonis ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

32P postlabeling; Biomarkers; DNA adducts; Human exposure; Nasal lavage

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; CHEMICAL COMPOUND; ENVIRONMENTAL MUTAGEN; PHOSPHORUS 32; XENOBIOTIC AGENT;

BILIARY EXCRETION; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DNA ADDUCT; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; METABOLITE; NORMAL HUMAN; NOSE MUCOSA; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0029935967     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s3471     Document Type: Conference Paper

References (20)

1. Miller JA. Carcinogenesis by chemicals: an overview. Cancer Res 30:559-576 (1970).
2. Miller E. Some current perspectives on chemical carcinogenesis in humans and experimental animals. Cancer Res 38:1479-1496 (1978).
3. Heidelberger C. Current trends in chemical carcinogenesis. Fed Proc 32:2154-2161 (1973).
4. Dipple A, Moschel RC, Bigger CAH. Polynuclear aromatic carcinogens. In: Chemical Carcinogens, Vol 1 (Searle CE, ed). American Chemical Society, Monograph 182. Washington: American Chemical Society, 1984;41-163.
5. Parke DV. Activation mechanisms to chemical toxicity. Arch Toxicol 60:5-15 (1987).
6. 32P-postlabeling assay. Carcinogenesis 13:1053-1074 (1992).
7. Hemminki K. DNA adducts, mutations and cancer. Carcinogenesis 14:2007-2012 (1993).
8. Rothman N, Stewart WF, Schulte PA. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker study design categories. Cancer Epidemiol Biomarkers Prev 4:301-311 (1995).
9. Andersson M, Svensson C, Andersson P, Pipkorn U. Objective monitoring of the allergic inflammatory response of the nasal mucosa in patients with hay fever during natural allergen exposure. Am Rev Respir Dis 139:911-914 (1989).
10. 32P-postlabeling of aromatic DNA adducts in white blood cells from iron foundry workers. Mutat Res 204:531-541 (1988).
11. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7:1543-1551 (1986).
12. Grzybowska E, Hemminki K, Szelinga J, Chorazy M. Seasonal variation of aromatic DNA adducts in human lymphocytes and granulocytes. Carcinogenesis 14:253-256 (1993).
13. Hemminki K, Söderling J, Ericson P, Norbeck HE, Segerbäck D. DNA adducts among personnel serving and loading diesel vehicles. Carcinogenesis 15:767-769 (1994).
14. Witek TJ. The nose as a target for adverse effects from the environment: applying advances in nasal physiologic measurements and mechanisms. Am J Ind Med 24:649-657 (1993)
15. Gervasi PG, Longo V, Naldi F, Panattoni G, Ursino F. Xenobiotic-metabolizing enzymes in human respiratory nasal mucosa. Biochem Pharmacol 41:177-184 (1991).
16. Getchell ML, Chen Y, Sparks DL, Ding X, Getchell TV. Immunohistochemical localization of a cytochrome P-450 isozyme in human nasal mucosa: age-related trends. Ann Otol Rhinol Laryngol 102:368-374 (1993).
17. Adams DR, Jones AM, Plopper CG, Serabjit-Singh CJ, Philpot RM. Distribution of cytochrome P-450 monoxygenase enzymes in the nasal mucosa of hamster and rat. Am J Anat 190:291-298 (1991).
18. Longo V, Mazzaccaro A, Ventura P, Gervasi PG. Drug-metabolizing enzymes in respiratory nasal mucosa and liver of cynomolgus monkey. Xenobiotica 22:427-431 (1992).
19. Longo V, Ingelman-Sundberg M. Acetone-dependent regulation of cytochrome P4502E1 and P4502B1 in rat nasal mucosa. Biochem Pharmacol 46:1945-1951 (1993).
20. Voigt JM, Guengerich FP, Baron J. Localization and induction of cytochrome P450 1A1 and aryl hydrocarbon hydroxylase activity in rat nasal mucosa. J Histochem Cytochem 41:877-885 (1993).